World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
139
Citations
75032
World Ranking
1752
National Ranking
1001

David L. Rimm publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David L. Rimm sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 689 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David L. Rimm D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David L. Rimm sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David L. Rimm is affiliated with Yale University in the United States and specializes primarily in Medicine, with a significant body of work in Biochemistry, Genetics and Molecular Biology.

Their research spans various subfields including Oncology, Cancer Research, Immunology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

Main topics covered in their work are:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Radiomics and Machine Learning in Medical Imaging
  • HER2/EGFR in Cancer Research
  • Cancer Cells and Metastasis
  • Monoclonal and Polyclonal Antibodies Research

Among the recent papers authored or coauthored by David L. Rimm are:

  • "PD-L1 as a biomarker of response to immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update," 2020, Journal of Clinical Oncology
  • "Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group," 2020, JNCI Journal of the National Cancer Institute
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update," 2020, Archives of Pathology & Laboratory Medicine
  • "Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue," 2022, JAMA Oncology

Frequent collaborators in their research include:

  • Thazin Nwe Aung
  • Myrto Moutafi
  • Lajos Pusztai
  • Niki Gavrielatou
  • Aileen I. Fernandez

David L. Rimm has published extensively in several scientific journals, with the highest number of publications in:

  • Cancer Research
  • Clinical Cancer Research
  • Modern Pathology
  • Journal of Clinical Oncology
  • Journal for ImmunoTherapy of Cancer

Best Publications

  • X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

    Robert L. Camp;Marisa Dolled-Filhart;David L. Rimm

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

    Levi A. Garraway;Hans R. Widlund;Mark A. Rubin;Gad Getz

  • Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

    Chad J. Creighton;Xiaoxian Li;Melissa Landis;J. Michael Dixon

  • Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

    Kaustav Bera;Kurt A. Schalper;David L. Rimm;Vamsidhar Velcheti

  • Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin.

    Karyn L. Cepek;Sunil K. Shaw;Sunil K. Shaw;Christina M. Parker;Gary J. Russell

  • PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Deborah Blythe Doroshow;Sheena Bhalla;Mary Beth Beasley;Lynette M. Sholl

  • Validation of tissue microarray technology in breast carcinoma.

    Robert L Camp;Lori A Charette;David L Rimm

  • Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex

    David L. Rimm;Erika R. Koslov;Partow Kebriaei;Carol D. Cianci

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

  • Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis

    Paul M. Weinberger;Ziwei Yu;Bruce G. Haffty;Diane Kowalski

  • Automated subcellular localization and quantification of protein expression in tissue microarrays.

    Robert L Camp;Gina G Chung;David L Rimm

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Programmed death ligand-1 expression in non-small cell lung cancer.

    Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou

  • Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.

    Joseph McLaughlin;Gang Han;Kurt A. Schalper;Daniel Carvajal-Hausdorf

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer

    David L. Rimm;Gang Han;Janis M. Taube;Eunhee S. Yi

  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    Scott Gettinger;Jungmin Choi;Katherine Hastings;Anna Truini

  • Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study

    Xiaohong R. Yang;Mark E. Sherman;David L. Rimm;Jolanta Lissowska

  • Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

    Keith S Hoek;David L Rimm;Kenneth R Williams;Hongyu Zhao

Frequent Co-Authors

Kurt A. Schalper
Kurt A. Schalper Yale University
Harriet M. Kluger
Harriet M. Kluger Yale University
Roy S. Herbst
Roy S. Herbst Yale University
Lajos Pusztai
Lajos Pusztai Yale University
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
Roberto Salgado
Roberto Salgado Peter MacCallum Cancer Centre
Bruce G. Haffty
Bruce G. Haffty Rutgers, The State University of New Jersey
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Yuval Kluger
Yuval Kluger Yale University
Scott N. Gettinger
Scott N. Gettinger Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but want alternative or complementary pathways, several online degree options can set you on a fulfilling journey in healthcare. Programs like a healthcare administration associate degree online are ideal if you want to develop management skills and enter the business side of healthcare quickly.

Nursing professionals can advance their education through asn to np programs, offering a streamlined bridge from an associate degree to a master’s as a nurse practitioner. For those interested in the preventative and nutrition side of medicine, earning an online bs in nutrition enables you to help others build healthier habits.

Aspiring leaders may consider pursuing one of the top cahme-accredited mha programs. These online master’s degrees equip graduates to oversee hospitals, clinics, and healthcare systems. Each of these pathways provides flexibility, diverse career options, and the ability to impact the future of health—often without putting medical school on hold.

Best Scientists Citing David L. Rimm

Trending Scientists

Recently Published Articles